Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

NCT05415098 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Nasopharyngeal Carcinoma
Castrate Resistant Prostate Cancer
Gastric Cancer
Ovarian Clear Cell Carcinoma
Mesothelioma
Sarcoma
Non Hodgkin Lymphoma
B Cell Lymphoma
Epithelioid Sarcoma

Interventions

DRUG: APG-5918

Sponsor

Ascentage Pharma Group Inc.